Tocilizumab in the treatment of systemic-onset juvenile idiopathic arthritis – single-centre experience

Tocilizumab in the treatment of systemic-onset juvenile idiopathic arthritis – single-centre experience

Bibliographic Details
Main Authors:	Justyna Roszkiewicz, Krzysztof Orczyk, Elżbieta Smolewska
Format:	Article
Language:	English
Published:	Termedia Publishing House 2018-10-01
Series:	Rheumatology
Subjects:	tocilizumab systemic-onset juvenile idiopathic arthritis treatment response biologic treatment effectiveness
Online Access:	https://www.termedia.pl/Tocilizumab-in-the-treatment-of-systemic-onset-juvenile-idiopathic-arthritis-single-centre-experience,18,34086,1,1.html

Similar Items

Sequential Tocilizumab and Tofacitinib Treatment for Systemic Juvenile Idiopathic Arthritis: a Case Report
by: Ye Zhang, et al.
Published: (2022-11-01)

THE CLINICAL AND PARACLINICAL EFFICACY OF TOCILIZUMAB IN JUVENILE IDIOPATHIC ARTHRITIS
by: Ninel REVENCO, et al.
Published: (2021-06-01)

Clinical improvement of renal amyloidosis in a patient with systemic-onset juvenile idiopathic arthritis who received tocilizumab treatment: a case report and literature review
by: Songkiat Chantarogh, et al.
Published: (2017-05-01)

Case reports Juvenile idiopathic arthritis complicated by amyloidosis with secondary nephrotic syndrome – effective treatment with tocilizumab
by: Małgorzata Kwiatkowska, et al.
Published: (2015-08-01)

Tocilizumab in Systemic Juvenile Idiopathic Arthritis: Response Differs by Disease Duration at Medication Initiation and by Phenotype of Disease
by: Xin Yan, et al.
Published: (2021-11-01)

Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry
by: Gerd Horneff, et al.
Published: (2017-11-01)

Tocilizumab in Juvenile Idiopathic Arthritis Associated Uveitis, a Narrative Review
by: Claudia Iannone, et al.
Published: (2023-02-01)

THE PHENOMENON OF NEUTROPENIA DURING TOCILIZUMAB THERAPY IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS
by: M. I. Kaleda, et al.
Published: (2018-01-01)

Tocilizumab for juvenile idiopathic arthritis: a single-center case series
by: Fatma Yazılıtaş, et al.
Published: (2020-03-01)

Optimization of systemic juvenile arthritis treatment regimens with correction of tocilizumab intravenous administration according to data of observational retrospective study
by: M. I. Kaleda, et al.
Published: (2019-05-01)

Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
by: Masaki Shimizu, et al.
Published: (2020-01-01)

Risk of significant cytopenias after treatment with tocilizumab in systemic juvenile arthritis patients with a history of macrophage activation syndrome
by: Kessler Elizabeth A, et al.
Published: (2012-08-01)

Systemic-onset juvenile idiopathic arthritis in a child with thalassemia major
by: Pitta Mary Dayana, et al.
Published: (2018-01-01)

Refractory systemic onset juvenile idiopathic arthritis: current challenges and future perspectives
by: William G. Ambler, et al.
Published: (2022-12-01)

Why and How Should We Assess the Cardiovascular Risk in Patients with Juvenile Idiopathic Arthritis? A Single-Centre Experience with Carotid Intima-Media Measurements
by: Marta Gruca, et al.
Published: (2023-02-01)

The impact of single nucleotide polymorphisms in MTHFR and MTRR genes on disease activity and the presence of methotrexate treatment side effects in children with juvenile idiopathic arthritis
by: Justyna Roszkiewicz, et al.
Published: (2023-05-01)

Juvenile idiopathic arthritis – classification and methods of treatment
by: Weronika Pawłocik, et al.
Published: (2023-04-01)

Disease evolution in systemic juvenile idiopathic arthritis: an international, observational cohort study through JIRcohort
by: M. Wallimann, et al.
Published: (2023-09-01)

Tocilizumab may slow radiographic progression in patients with systemic or polyarticular-course juvenile idiopathic arthritis: post hoc radiographic analysis from two randomized controlled trials
by: Clara Malattia, et al.
Published: (2020-09-01)

Clinical and Laboratory Profile of Patients with Newly Diagnosed Juvenile Idiopathic Arthritis: An Observational Study from a Tertiary Care Centre, Karnataka, India
by: Sivaranjani Sethupandi, et al.
Published: (2023-04-01)

Causes of invalidity in patients with juvenile idiopathic arthritis
by: T A Slielepina
Published: (2005-04-01)

Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches
by: Lina N. Zaripova, et al.
Published: (2021-08-01)

Efficacy and safety of canakinumab as a second line biologic after tocilizumab treatment failure in children with systemic juvenile idiopathic arthritis: A single-centre cohort study using routinely collected health data
by: Ekaterina Alexeeva, et al.
Published: (2023-02-01)

RAPID EFFECT OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS
by: E Yu Panasyuk, et al.
Published: (2011-08-01)

Elbow monoarthritis: an atypical onset of juvenile idiopathic arthritis Elbow monoarthritis: an atypical juvenile idiopathic arthritis onset
by: G. Simonini, et al.
Published: (2012-07-01)

Interstitial lung disease occurring shortly after tocilizumab infusion in a patient with polyarticular juvenile idiopathic arthritis: a case report
by: Koichi Sugihara, et al.
Published: (2021-09-01)

EFFICACY AND SAFETY OF TOCILIZUMAB IN CHILDREN WITH SYSTEMIC JUVENILE ARTHRITIS IN CLINICAL PRACTICE
by: M. I. Kaleda, et al.
Published: (2015-04-01)

Efficacy of rehabilitation therapy on hospital stage of treatment of patients with juvenile idiopathic arthritis
by: T A Shelepina, et al.
Published: (2008-06-01)

Interpretation on the 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis
by: ZHONG Linqing, et al.
Published: (2022-11-01)

First-line options for systemic juvenile idiopathic arthritis treatment: an observational study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans
by: Timothy Beukelman, et al.
Published: (2022-12-01)

No radiographic wrist damage after treatment to target in recent-onset juvenile idiopathic arthritis
by: P. C. E. Hissink Muller, et al.
Published: (2019-09-01)

The use of radiosynovectomy in patients with juvenile idiopathic arthritis. Assessment of treatment efficacy and safety
by: Agnieszka Gazda, et al.
Published: (2021-08-01)

A systemic type of juvenile idiopathic (rheumatoid) arthritis in children and adolescents: new in the treatment (review of literature and own observations)
by: L.F. Bogmat, et al.
Published: (2017-05-01)

Juvenile Idiopathic Arthritis Onset in a Neonate: A Rare Case Report
by: Abdolreza Malek, et al.
Published: (2017-06-01)

Chinese Expert Consensus on Juvenile Idiopathic Arthritis-associated Uveitis (2023)
by: The Subspecialty Group of Immunology, the Society of Pediatrics, Chinese Medical Association, et al.
Published: (2023-03-01)

Case report: Success of allogeneic hematopoietic stem cell transplantation for refractory systemic-onset juvenile idiopathic arthritis
by: Camille Beaufils, et al.
Published: (2023-10-01)

Adherence, helpfulness and barriers to treatment in juvenile idiopathic arthritis – data from a German Inception cohort
by: Sabine Kirchner, et al.
Published: (2023-04-01)

When a patient suspected with juvenile idiopathic arthritis turns out to be diagnosed with an infectious disease – a review of Lyme arthritis in children
by: Krzysztof Orczyk, et al.
Published: (2017-05-01)

Uveitis in patients with oligoarticular juvenile idiopathic arthritis and juvenile spondyloarthritis/enthesitis related arthritis: is there any difference?
by: A. Martins, et al.
Published: (2023-05-01)

Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
by: Sofia Lanz, et al.
Published: (2021-08-01)